App aims to ease cancer treatment for minorities

NCT ID NCT05812274

Terminated Symptom relief Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a mobile app called Apricity CARE to help ethnic and racial minority patients with non-small cell lung cancer report side effects from immunotherapy. The goal was to reduce treatment delays and hospital visits. The study was stopped early, but it aimed to improve how patients and doctors manage treatment side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center

New York, New York, 10032, United States
Montefiore Health Center

New York, New York, 10029, United States
Mount Sinai School of Medicine

New York, New York, 10029, United States
NYU Medical Center

New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.